Background: We set out in this study to demonstrate the adverse effect profile of methotrexate when used in the treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in a district ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

Discover the signs of psoriatic arthritis, from joint pain and skin changes to nail damage and fatigue, plus the latest treatment options for this condition.

When patients reported a symptom that could constitute an adverse effect of treatment with methotrexate, this was thoroughly investigated by means of history, physical examination and biochemical ...

The twice-daily treatment has been approved for adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate. Xeljanz ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

erasmusmc.nl Objectives Many female rheumatoid arthritis (RA) patients attempting to conceive ... Cox regression analysis was used to study the association of disease characteristics and medication ...

rheumatoid arthritis radiography disease modifying antirheumatic drugs DMARDs, disease modifying antirheumatic drugs FDA, Food and Drug Administration MTX, methotrexate NSAIDs, non-steroidal ...

Biologic ustekinumab (Stelara) was approved in 2013 for the treatment of moderate to severe psoriatic arthritis in adult patients. It was first approved in 2009 for psoriasis. Ustekimumab can be used ...

Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data ...